Literature DB >> 20859609

[Sacral neuromodulation in urology. The emperor's new clothes or effective high-tech medicine?].

M R Hoda1, P Fornara.   

Abstract

Sacral nerve modulation (SNM) is an innovative, minimally invasive treatment that uses chronic low-level electrical stimulation of the sacral plexus to recruit residual physiological function of urinary bladder detrusor, pelvic floor muscles, and the anorectal continence structures. Classic indications for sacral neuromodulation in urology are refractory overactive bladder symptoms (urinary urgency ± incontinence) and chronic nonobstructive urinary retention. SNM also offers a therapeutic alternative in refractory chronic pelvic pain syndrome. The exact mechanism of action is still unknown, but it is assumed that electrical stimulation of the sacral nerves leads to neuromodulation as well as clinically beneficial effects in the pelvic floor, the sphincter complex, and the distal colorectum. SNM is a multistep procedure. In a test phase of so-called percutaneous or peripheral nerve evaluation (PNE), the effect of sacral neuromodulation is evaluated over days or weeks during which a bladder diary/pain protocol is kept. The predictive value of PNE is high, while morbidity and surgical trauma are low. The screening phase provided by PNE makes this technique unique and offers an ideal instrument for patient selection. After final implantation of the neurostimulator (InterStim II), the long-term success rate is over 60-90%. At our clinic, 42 patients underwent a PNE procedure between January 2009 and June 2010. Of these, 34 patients had a >50% success rate and had been implanted with the InterStim II device (80.9%). The success rates were 83% for overactive bladder and 89% for chronic retention (mean follow-up 7.8 months). In addition to the surgical procedure, the exact indication and postoperative care are important prerequisites of successful therapy. To date, no information on the number of implanted stimulators in Germany is available. This suggests the need for establishment of a national prospective registry. It would also be appropriate that the experts from the implantation centers form a working group.

Entities:  

Mesh:

Year:  2010        PMID: 20859609     DOI: 10.1007/s00120-010-2395-4

Source DB:  PubMed          Journal:  Urologe A        ISSN: 0340-2592            Impact factor:   0.639


  21 in total

1.  Sacral nerve stimulation for treatment of refractory urinary urge incontinence. Sacral Nerve Stimulation Study Group.

Authors:  R A Schmidt; U Jonas; K A Oleson; R A Janknegt; M M Hassouna; S W Siegel; P E van Kerrebroeck
Journal:  J Urol       Date:  1999-08       Impact factor: 7.450

2.  Complications and troubleshooting of two-stage sacral neuromodulation therapy: a single-institution experience.

Authors:  Adonis Hijaz; Sandip P Vasavada; Firouz Daneshgari; Hasan Frinjari; Howard Goldman; Raymond Rackley
Journal:  Urology       Date:  2006-09-18       Impact factor: 2.649

3.  Long term results of neuromodulation by sacral nerve stimulation for lower urinary tract symptoms: a retrospective single center study.

Authors:  A C van Voskuilen; D J A J Oerlemans; E H J Weil; R A de Bie; Ph E V A van Kerrebroeck
Journal:  Eur Urol       Date:  2006-01-04       Impact factor: 20.096

4.  Bladder pacemaker: scientific basis and clinical future.

Authors:  E A Tanagho; R A Schmidt
Journal:  Urology       Date:  1982-12       Impact factor: 2.649

5.  Predictive factors for sacral neuromodulation in chronic lower urinary tract dysfunction.

Authors:  W A Scheepens; M M G J Jongen; F H M Nieman; R A de Bie; E H J Weil; P E V van Kerrebroeck
Journal:  Urology       Date:  2002-10       Impact factor: 2.649

6.  Early sacral neuromodulation prevents urinary incontinence after complete spinal cord injury.

Authors:  Karl-Dietrich Sievert; Bastian Amend; G Gakis; P Toomey; A Badke; H P Kaps; Arnulf Stenzl
Journal:  Ann Neurol       Date:  2010-01       Impact factor: 10.422

7.  Long-term effectiveness of sacral nerve stimulation for refractory urge incontinence.

Authors:  R A Janknegt; M M Hassouna; S W Siegel; R A Schmidt; J B Gajewski; D A Rivas; M M Elhilali; D C Milam; P E van Kerrebroeck; H E Dijkema; A A Lycklama à Nÿeholt; M Fall; U Jonas; F Catanzaro; C J Fowler; K A Oleson
Journal:  Eur Urol       Date:  2001-01       Impact factor: 20.096

Review 8.  Efficacy and adverse events of sacral nerve stimulation for overactive bladder: A systematic review.

Authors:  Nazema Y Siddiqui; Jennifer M Wu; Cindy L Amundsen
Journal:  Neurourol Urodyn       Date:  2010       Impact factor: 2.696

9.  Sacral nerve stimulation for voiding dysfunction: One institution's 11-year experience.

Authors:  Suzette E Sutherland; Ann Lavers; Angeline Carlson; Cindy Holtz; Jyothi Kesha; Steven W Siegel
Journal:  Neurourol Urodyn       Date:  2007       Impact factor: 2.696

Review 10.  Neurostimulation for lower urinary tract voiding problems.

Authors:  V Grüenewald; U Jonas
Journal:  Curr Urol Rep       Date:  2000-10       Impact factor: 2.862

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.